Terns Pharmaceuticals

Terns Pharmaceuticals(TERN)

FOSTER CITY, CA
Pharmaceutical

Focus: Small Molecules - Liver focus

Terns Pharmaceuticals is a life sciences company focused on Small Molecules - Liver focus.

Neurology
Funding Stage
PUBLIC
Open Jobs
3

Pipeline & Clinical Trials

Clinical Trials (1)
NCT04897594AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis
Phase 1
Clinical Trials (1)
NCT06163430A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Phase 1/2
Clinical Trials (1)
NCT05415722DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis
Phase 2
Phase 2
Clinical Trials (1)
NCT06854952A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
Phase 2
Clinical Trials (1)
NCT04328077LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)
Phase 2

Open Jobs (3)

Interview Prep Quick Facts
Portfolio: 5 clinical trials
SEC Filings: 2 available
Open Roles: 3 active jobs

Financials (FY2024)

R&D Spend
$63M60%
Net Income
-$90M
Cash
$80M

Hiring Trend

Stable
3
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles